Health technology agency insights: informing modification of a qualitative benefit risk framework for health technology reassessment of prescription medications

16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified ...

Read more →

Canada decides: Leading parties plan to tackle ways to make medicine affordable

16 September 2019 - Canadian voters will be hearing a lot about a new national prescription drug program to fill a ...

Read more →

Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans

11 September 2019 - Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug ...

Read more →

New rules will keep the best medications from desperate Canadians

12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...

Read more →

Erosion of physician and patient treatment choice continues - Alliance for Safe Biologic Medicines raises concerns for patients as British Columbia expands biologics forced switching policy

10 September 2019 - On 5 September, the Government of British Columbia announced that it would be forcibly switching 1,700 patients ...

Read more →

Canada releases final amendments to patented medicines pricing regulations

9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...

Read more →

Trudeau’s drug price overhaul is set to cost drug makers billions

6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...

Read more →

NDP promises to restore special drugs program

4 September 2019 - Province paid deductible for chronic patients from 1968 to 2018. ...

Read more →

Manitoba Liberals promise to opt into national Pharmacare program

4 September 2019 - Liberals say Pallister won't sign onto such a program but Tories say they've been trying to get ...

Read more →

'Outrageously expensive': new drug approval will cost Ontario family 100K per year

30 August 2019 - Drug cost jumped from $5,000 to more than $100,000 per year. ...

Read more →

Drug-price reforms need not affect research on rare diseases – or the Canadians who have them

26 August 2019 - On 9 August, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for ...

Read more →

Companies file suit in Canada challenging new rules to lower drug prices

23 August 2019 - Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging ...

Read more →

Updated procedure and submission guidelines for the CADTH Common Drug Review

22 August 2019 - The Procedure and Submission Guidelines for the CADTH Common Drug Review has been updated with the ...

Read more →

Empirical evidence supports critics of Patented Medicine Prices Review Board regulations

21 August 2019 - Canadian Health Policy Institute, a Toronto-based private-sector think-tank established in 2012, has published several studies that bolster ...

Read more →

Bring in pharmacare now, health experts ask federal leaders

15 August 2019 - Signatories include professors of medicine, pharmacy, nursing, economics, political science and law. ...

Read more →